Metraipolis › archive › dc_dfbfbc6cc0fc

Ferroportin deficiency drives olaparib resistance in ovarian cancer via the cGAS-STING-STAT3 survival axis — Europe PMC PMID:42968661

Source: Europe PMC (en)
Original: https://europepmc.org/article/MED/42968661
DOI: 10.1002/ctm2.70885
License (as archived): solo-consultazione
Archived: 2026-11-07T15:51:24.674Z
SHA-256 of the archived text: 028b68a516e330ce60b9fbaae6b418234b7edef6d2d15168c9f612b4c142d401
Stable URL of this page: https://metraipolis.com/documento/dc_dfbfbc6cc0fc

How to cite

Ferroportin deficiency drives olaparib resistance in ovarian cancer via the cGAS-STING-STAT3 survival axis — Europe PMC PMID:42968661 — Europe PMC (en), https://europepmc.org/article/MED/42968661 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_dfbfbc6cc0fc (Metraipolis archive dc_dfbfbc6cc0fc, sha256 028b68a516e330ce60b9fbaae6b418234b7edef6d2d15168c9f612b4c142d401)

BibTeX

@misc{dcdfbfbc6cc0fc,
  title = {Ferroportin deficiency drives olaparib resistance in ovarian cancer via the cGAS-STING-STAT3 survival axis — Europe PMC PMID:42968661},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42968661},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_dfbfbc6cc0fc; sha256 028b68a516e330ce60b9fbaae6b418234b7edef6d2d15168c9f612b4c142d401},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42968661. Agents can read the archived copy with the MCP tool read_document.